Correlation Between R S and Akums Drugs
Specify exactly 2 symbols:
By analyzing existing cross correlation between R S Software and Akums Drugs and, you can compare the effects of market volatilities on R S and Akums Drugs and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in R S with a short position of Akums Drugs. Check out your portfolio center. Please also check ongoing floating volatility patterns of R S and Akums Drugs.
Diversification Opportunities for R S and Akums Drugs
0.86 | Correlation Coefficient |
Very poor diversification
The 3 months correlation between RSSOFTWARE and Akums is 0.86. Overlapping area represents the amount of risk that can be diversified away by holding R S Software and Akums Drugs and in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Akums Drugs and R S is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on R S Software are associated (or correlated) with Akums Drugs. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Akums Drugs has no effect on the direction of R S i.e., R S and Akums Drugs go up and down completely randomly.
Pair Corralation between R S and Akums Drugs
Assuming the 90 days trading horizon R S Software is expected to under-perform the Akums Drugs. In addition to that, R S is 1.11 times more volatile than Akums Drugs and. It trades about -0.6 of its total potential returns per unit of risk. Akums Drugs and is currently generating about -0.17 per unit of volatility. If you would invest 61,870 in Akums Drugs and on December 2, 2024 and sell it today you would lose (16,320) from holding Akums Drugs and or give up 26.38% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Strong |
Accuracy | 100.0% |
Values | Daily Returns |
R S Software vs. Akums Drugs and
Performance |
Timeline |
R S Software |
Akums Drugs |
R S and Akums Drugs Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with R S and Akums Drugs
The main advantage of trading using opposite R S and Akums Drugs positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if R S position performs unexpectedly, Akums Drugs can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Akums Drugs will offset losses from the drop in Akums Drugs' long position.R S vs. Electronics Mart India | R S vs. Indian Metals Ferro | R S vs. Nahar Industrial Enterprises | R S vs. TVS Electronics Limited |
Akums Drugs vs. Kavveri Telecom Products | Akums Drugs vs. Hi Tech Pipes Limited | Akums Drugs vs. DMCC SPECIALITY CHEMICALS | Akums Drugs vs. Bhagiradha Chemicals Industries |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.
Other Complementary Tools
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital |